278 related articles for article (PubMed ID: 23664547)
1. Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.
Koulouridis I; Alfayez M; Tighiouart H; Madias NE; Kent DM; Paulus JK; Jaber BL
Am J Kidney Dis; 2013 Oct; 62(4):730-7. PubMed ID: 23664547
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.
Zipursky J; Macdonald EM; Hollands S; Gomes T; Mamdani MM; Paterson JM; Lathia N; Juurlink DN
PLoS Med; 2014 Sep; 11(9):e1001736. PubMed ID: 25268962
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
[TBL] [Abstract][Full Text] [Related]
5. Extreme hypomagnesemia: characteristics of 119 consecutive inpatients.
Cheminet G; Clain G; Jannot AS; Ranque B; Passeron A; Michon A; De Luna G; Diehl JL; Oudard S; Cellier C; Karras A; Vedié B; Prot-Bertoye C; Pouchot J; Arlet JB
Intern Emerg Med; 2018 Dec; 13(8):1201-1209. PubMed ID: 29951810
[TBL] [Abstract][Full Text] [Related]
6. Hypomagnesemia and proton-pump inhibitors.
Famularo G; Gasbarrone L; Minisola G
Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
[TBL] [Abstract][Full Text] [Related]
7. Hypomagnesemia in a department of internal medicine.
Liamis G; Liberopoulos E; Alexandridis G; Elisaf M
Magnes Res; 2012 Dec; 25(4):149-58. PubMed ID: 23261516
[TBL] [Abstract][Full Text] [Related]
8. The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study.
Toprak O; Sarı Y; Koç A; Sarı E; Kırık A
Clin Interv Aging; 2017; 12():437-444. PubMed ID: 28280316
[TBL] [Abstract][Full Text] [Related]
9. Hypomagnesemia During Teriparatide Treatment in Osteoporosis: Incidence and Determinants.
Bégin MJ; Ste-Marie LG; Coupal L; Ethier J; Räkel A
J Bone Miner Res; 2018 Aug; 33(8):1444-1449. PubMed ID: 29637622
[TBL] [Abstract][Full Text] [Related]
10. The association of proton pump inhibitors and hypomagnesemia in the community setting.
Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitors and Hypomagnesemia in Older Inpatients: An Observational Study.
Anna Vermeulen Windsant-van den Tweel AM; Derijks HJ; Gadiot NPPM; Keijsers CJPW
Sr Care Pharm; 2022 Dec; 37(12):623-630. PubMed ID: 36461136
[No Abstract] [Full Text] [Related]
12. Uses of proton pump inhibitors and hypomagnesemia.
Gau JT; Yang YX; Chen R; Kao TC
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):553-9. PubMed ID: 22337212
[TBL] [Abstract][Full Text] [Related]
13. Posterior reversible encephalopathy syndrome (PRES) and hypomagnesemia: A frequent association?
Chardain A; Mesnage V; Alamowitch S; Bourdain F; Crozier S; Lenglet T; Psimaras D; Demeret S; Graveleau P; Hoang-Xuan K; Levy R
Rev Neurol (Paris); 2016; 172(6-7):384-8. PubMed ID: 27371132
[TBL] [Abstract][Full Text] [Related]
14. Hypomagnesemia in hemodialysis patients: role of proton pump inhibitors.
Alhosaini M; Walter JS; Singh S; Dieter RS; Hsieh A; Leehey DJ
Am J Nephrol; 2014; 39(3):204-9. PubMed ID: 24577494
[TBL] [Abstract][Full Text] [Related]
15. [Emergent adverse effects of proton pump inhibitors].
Bourne C; Charpiat B; Charhon N; Bertin C; Gouraud A; Mouchoux C; Skalli S; Janoly-Dumenil A
Presse Med; 2013 Feb; 42(2):e53-62. PubMed ID: 23237784
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients.
Recart DA; Ferraris A; Petriglieri CI; Alonso Serena M; Bonella MB; Posadas-Martinez ML
Intern Emerg Med; 2021 Apr; 16(3):711-717. PubMed ID: 33001349
[TBL] [Abstract][Full Text] [Related]
17. Recent safety concerns with proton pump inhibitors.
Chen J; Yuan YC; Leontiadis GI; Howden CW
J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
[TBL] [Abstract][Full Text] [Related]
18. [The Incidence of Cisplatin-induced Hypomagnesemia in Cervical Cancer Patients Receiving Cisplatin Alone].
Yamamoto Y; Watanabe K; Matsushita H; Tsukiyama I; Matsuura K; Wakatsuki A
Yakugaku Zasshi; 2017; 137(1):79-82. PubMed ID: 28049899
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
Luk CP; Parsons R; Lee YP; Hughes JD
Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
[TBL] [Abstract][Full Text] [Related]
20. Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients.
Van Ende C; Van Laecke S; Marechal C; Verbeke F; Kanaan N; Goffin E; Vanholder R; Jadoul M
J Nephrol; 2014 Dec; 27(6):707-11. PubMed ID: 24816563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
